the duodenum, "neuromuscular and vascular hamartomas", and gangliocytic paragangliomas may be associated with many of the former lesions that are undoubtedly associated with mucosal damage such as that seen in Crohn's disease.'0 Furthermore, the occurrence of areas of neuromuscular hyperplasia, which may include ganglion cells, is well recognised in Crohn's disease. The histology of the tumours presented shows well circumscribed lesions with no adjacent mucosal abnormality. Case 1 seems to have arisen in the 12 month period between sigmoidoscopic examinations and may be directly related to the site of previous surgery. Although a mucosal lesion may seem to have healed, the chronic inflammatory reaction within the tumour may be evidence of previous surgery.
The identification of a gastrointestinal ganglioneuroma necessitates Pyrolysis mass spectra vary with the age and cultural conditions of the organisms before pyrolysis2 so that pyrolysis mass spectrometry cannot assign permanent type designations. However, if organisms are prepared under identical conditions and then examined by pyrolysis mass spectrometry within a single machine batch, the system is highly discriminatory. Mycobacteria form a highly disparate group of organisms with a wide range of different growth cycles and optimal growth temperatures. Consequently, pyrolysis mass spectrometry is only likely to be useful when analysing within groups of mycobacteria of closely similar growth pattern. We recently adopted this approach in analysing members of the M tuberculosis complex. Pyrolysis mass spectrometry was able to distinguish M tuberculosis from M bovis, and also showed the close similarity between M bovis and M africanum. 3 An emerging clinical problem is the differentiation of mycobacteria isolated from immunocompromised patients, particularly those with AIDS. In most cases the organism is likely to belong to the Mycobacterium aviumintracellulare (MAI) complex, but recent reports suggest that other species such as M xenopi can also infect these patients.45 An ability to distinguish rapidly M xenopi from organisms of the MAI complex may become important in epidemiology and patient management.
Conventional differentiation relies on relative sensitivity to isoniazid, growth on tellurite containing media and thermophilicity. All these tests require subculture, take some time to complete, and are not always definitive. Detection of 2-Docosanol has been suggested as a rapid positive test for the identification of M xenopi, but requires access to gas chromatography. 6 On primary isolation both MAI complex and M xenopi appear as slow-growing, Tween-80 negative mycobacteria. We have done a preliminary study to assess the potential of pyrolysis mass spectrometry to distinguish rapidly and positively M xenopi from organisms of the MAI complex in this context. 
